/ABOUT US
The people behind a more precise way to help you get unstuck.
/our mission
Pharia's mission is to give people a direct way to shift what therapy, habits, and medication haven't fully reached — using targeted brain stimulation, clinical precision, and a protocol designed for real life.
/our vision
We envision a future where the mind is no longer opaque or passively managed. Where people have tools to understand what's happening, intervene directly, and build lives aligned with how they actually want to think and feel.
/OUR VALUES
The values that guide how we build and practice.
Agency
We exist to empower people to make the changes they want.
Our experts and clinicians guide you, but you remain in control of your goals, decisions, and timing. We believe healthcare systems should expand what's possible for our health, not limit it.
Care at the frontiers
We work at the frontiers of neuroscience and innovation.
It's a privilege to work with the mind, our most important asset. We apply new approaches only when evidence, safety, and context are right, translating frontier science into care you can trust.
Timely access
When the science is ready and the need is real, access shouldn't be delayed by slow or exclusionary systems.
We reduce unnecessary barriers and make effective solutions available now.
Transparent communication
Transparency is essential to building trust and legitimacy in new frontiers.
We communicate honestly when something isn't a fit, where the evidence is strong or limited, and what we're still learning - so you can make informed decisions.
Respect for complexity
We honor the complexity of the mind and this work.
We don't promise simple fixes or force certainty. We measure to learn, move carefully when it matters, and take responsibility for translating nuance into clarity.
0
response rate to
the treatment
0
of people experience
noticeable changes
Built by clinicians and researchers with deep experience in neuromodulation and mental health.
Jeeshan Chowdhury, MD, PhD
Co-founder
Jeeshan Chowdhury is an MD/PhD and studied at Oxford as a Rhodes Scholar. He is a seasoned entrepreneur, having founded and sold ListRunner, a digital tool for frontline clinical teams, and founded Journey Colab, a company dedicated to advancing psychedelic medicine for substance use treatment. Journey Colab was part of Sam Altman's inaugural cohort of Apollo Projects Fund.
Anna Martirosyan
Co-founder
Anna Martirosyan spent the last several years advancing cutting-edge treatments for mental health at Journey Colab, a company advancing psychedelic medicines for substance use treatment. Prior, she spent several years supporting growth equity firms in healthcare and software investing at Bain & Co. She holds a BA in Psychology, with an emphasis in neuroscience, and BA in Economics from the University of California, Berkeley.
David Carreon, MD
Medical Director, Lead Psychiatrist
Dr. Carreon is a board-certified psychiatrist who received his psychiatric training at Stanford University. He has been practicing since 2014, with a specialty in TMS and other neuromodulation techniques. In 2018, he founded Acacia Clinics, one of the nation's leading treatment and research centers specializing in TMS and other novel treatments. For the past five years, Dr. Carreon has also conducted research at Stanford in the Etkin Neuroscience Lab, primarily focusing on the underlying physiology of psychiatric disorders.
Nathan Meng, MD
Clinics Director
Dr. Meng is a physician who trained at Stanford University. In 2018, alongside Dr. Carreon, he founded Acacia Clinics one of the nation's leading treatment and research centers specializing in TMS and other novel treatments. Prior, he served as the Chief Technology Officer of Ameda, Inc., a privately-held medical device company in the mother-baby space. While at Stanford, Dr. Meng was also the Clinical Lead at Embrace, Inc., a start-up medical device company, also in the mother-baby space.